Harrow Enterprise Value Over E B I T D A from 2010 to 2024
| HROWL Stock | USD 25.35 0.05 0.20% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter 49.54488351 | Current Value 52.02 | Quarterly Volatility 138.70275277 |
Check Harrow Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harrow Health's main balance sheet or income statement drivers, such as Interest Expense of 22.4 M, Selling General Administrative of 70.3 M or Selling And Marketing Expenses of 5.2 M, as well as many indicators such as Price To Sales Ratio of 2.67, Dividend Yield of 6.0E-4 or PTB Ratio of 4.9. Harrow financial statements analysis is a perfect complement when working with Harrow Health Valuation or Volatility modules.
Harrow | Enterprise Value Over E B I T D A |
Latest Harrow Health's Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Harrow Health 8625 over the last few years. It is Harrow Health's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harrow Health's overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Harrow Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | (27.41) | |
| Coefficient Of Variation | (505.98) | |
| Mean Deviation | 77.21 | |
| Median | (4.35) | |
| Standard Deviation | 138.70 | |
| Sample Variance | 19,238 | |
| Range | 628 | |
| R-Value | 0.43 | |
| Mean Square Error | 16,808 | |
| R-Squared | 0.19 | |
| Significance | 0.11 | |
| Slope | 13.47 | |
| Total Sum of Squares | 269,338 |
Harrow Enterprise Value Over E B I T D A History
About Harrow Health Financial Statements
Harrow Health investors utilize fundamental indicators, such as Enterprise Value Over E B I T D A, to predict how Harrow Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | 49.54 | 52.02 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Harrow Health Correlation against competitors. For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Equity 0.4484 |
The market value of Harrow Health 8625 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.